Literature DB >> 27826571

Lymph node dissection after pulmonary resection for lung cancer: a mini review.

Stylianos Korasidis1, Cecilia Menna2, Claudio Andreetti1, Giulio Maurizi1, Antonio D'Andrilli1, Anna Maria Ciccone1, Francesco Cassiano1, Erino Angelo Rendina1, Mohsen Ibrahim1.   

Abstract

An accurate staging of a malignant disease is imperative in order to plan pre- and post-operative therapy, define prognosis and compare studies. According to the European Society of Thoracic Surgeons (ESTS) guidelines a systematic lymph node (LN) dissection is recommended in all cases of pulmonary resection for non-small cell lung cancer (NSCLC). The current lung cancer staging system considers the lymphatic stations involved but not the number of LNs. Up to date, published scientific studies on hilar and mediastinal lymphadenectomy mainly have been regarded the type of LN dissection procedure after pulmonary resection (selected LN biopsy, LN sampling, systematic nodal dissection, lobe specific nodal dissection and extended LN dissection) focusing particularly on the comparison between mediastinal LN dissection (MLND) and mediastinal LN sampling (MLNS). Recently, further investigations have been concentrated on surgical approach (videothoracoscopic vs. thoracotomic approach) used to perform pulmonary resection and following LN dissection in order to achieve a complete mediastinal lymphadenectomy. This short synthesis aims to present the current experiences in this setting.

Entities:  

Keywords:  Lymph node dissection; lung cancer; pulmonary resection

Year:  2016        PMID: 27826571      PMCID: PMC5075854          DOI: 10.21037/atm.2016.09.09

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  21 in total

1.  Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically-treated non-small cell lung cancer (NSCLC).

Authors:  L Luzzi; P Paladini; C Ghiribelli; L Voltolini; M Di Bisceglie; A D'Agata; M Cacchiarelli; G Gotti
Journal:  Lung Cancer       Date:  2000-11       Impact factor: 5.705

2.  Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database.

Authors:  Subroto Paul; Nasser K Altorki; Shubin Sheng; Paul C Lee; David H Harpole; Mark W Onaitis; Brendon M Stiles; Jeffrey L Port; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2010-02       Impact factor: 5.209

3.  Video-assisted thoracic surgery lobectomy: experience with 1,100 cases.

Authors:  Robert J McKenna; Ward Houck; Clark Beeman Fuller
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

4.  Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Eastern Cooperative Oncology Group.

Authors:  S M Keller; S Adak; H Wagner; D H Johnson
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

5.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

6.  A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer.

Authors:  Yi long Wu; Zhi-fan Huang; Si-yu Wang; Xue-ning Yang; Wei Ou
Journal:  Lung Cancer       Date:  2002-04       Impact factor: 5.705

7.  A prospective trial of systematic nodal dissection for lung cancer by video-assisted thoracic surgery: can it be perfect?

Authors:  Motoyasu Sagawa; Masami Sato; Akira Sakurada; Yuji Matsumura; Chiaki Endo; Masashi Handa; Takashi Kondo
Journal:  Ann Thorac Surg       Date:  2002-03       Impact factor: 4.330

8.  Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

Authors:  Paul De Leyn; Christophe Dooms; Jaroslaw Kuzdzal; Didier Lardinois; Bernward Passlick; Ramon Rami-Porta; Akif Turna; Paul Van Schil; Frederico Venuta; David Waller; Walter Weder; Marcin Zielinski
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-26       Impact factor: 4.191

9.  Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer.

Authors:  Robert E Merritt; Chuong D Hoang; Joseph B Shrager
Journal:  Ann Thorac Surg       Date:  2013-07-31       Impact factor: 4.330

10.  Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors.

Authors:  Daniel J Boffa; Mark S Allen; Joshua D Grab; Henning A Gaissert; David H Harpole; Cameron D Wright
Journal:  J Thorac Cardiovasc Surg       Date:  2007-12-21       Impact factor: 5.209

View more
  2 in total

1.  Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.

Authors:  Margarita Kirienko; Luca Cozzi; Lidija Antunovic; Lisa Lozza; Antonella Fogliata; Emanuele Voulaz; Alexia Rossi; Arturo Chiti; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-24       Impact factor: 9.236

Review 2.  [A Review on Comparison of Lobectomy and Segmentectomy in the Treatment of 
Early Stage Non-small Cell Lung Cancer].

Authors:  Liang Chen; Wentao Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.